Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Irinotecan-based Chemotherapy in Metastatic Colorectal Cancer
NCT00064181Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2003
- Primary completion
- Jan 2005
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of celecoxib in metastatic colorectal cancer (mCRC), sponsored by European Organisation for Research and Treatment of Cancer. Started May 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00064181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064181.